Your browser doesn't support javascript.
loading
Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.
Kieny, Alice; Cribier, Bernard; Meyer, Nicolas; Velten, Michel; Jégu, Jérémie; Lipsker, Dan.
Afiliación
  • Kieny A; Faculté de Médecine, Université de Strasbourg et Service de Dermatologie, Hôpital Civil, Strasbourg, France.
  • Cribier B; Faculté de Médecine, Université de Strasbourg et Service de Dermatologie, Hôpital Civil, Strasbourg, France.
  • Meyer N; Laboratoire d'Epidémiologie et de Santé Publique, EA3430, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.
  • Velten M; Service de Santé Publique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Jégu J; Service de Santé Publique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Lipsker D; Laboratoire de Biostatistiques, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.
Int J Cancer ; 144(4): 741-745, 2019 02 15.
Article en En | MEDLINE | ID: mdl-30194728
ABSTRACT
Merkel Cell Carcinoma (MCC) is an aggressive skin cancer with an increasing incidence. Population-based epidemiologic data about MCC in France are rare. Our study aims to describe the epidemiology of MCC in Bas-Rhin, Northeastern of France, between 1985 and 2013. Data were collected from the Bas-Rhin Cancer Registry. We measured age-adjusted incidence rates (per 100,000 person-years) and effect of age, sex and period of diagnosis on survival. The world age-standardized incidence rate was 0.17 and it quadrupled between 1985 and 2013. Cases (n = 111) occurred mostly in women (60%) and in persons ≥70 years of age (74%). Incidence rates was close for men (0.18) and women (0.16) and was 25-time higher in people ≥70 years of age but incidence rate similarly increased between 1985 and 2013 in persons older and younger than 70 years. Net 5-year survival was 48.5%; female sex and younger age were positive predictors of survival. Given the low number of cases, incidence and survival data should be interpreted with caution. Incidence of MCC in Bas-Rhin quadrupled between 1985 and 2013. The highest incidence rate was observed in people ≥70 years. Better survival was associated with female sex and younger age. We hypothesize that MCC will still increase and be diagnosed in increasingly younger patients in next generations.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Sistema de Registros / Vigilancia de la Población Tipo de estudio: Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células de Merkel / Sistema de Registros / Vigilancia de la Población Tipo de estudio: Incidence_studies / Prognostic_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Francia